| Net Cash Provided by (Used in) Operating Activities |
$4,815,000 |
USD |
25% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$12,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$5,000 |
USD |
-25% |
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
24,215,000 |
shares |
181% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$14,277,000 |
USD |
-34% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$16,100,000 |
USD |
109% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$16,114,000 |
USD |
109% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$136,000 |
USD |
-33% |
Q4 2024 |
FY 2024 |
| Depreciation |
$19,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$5,000 |
USD |
25% |
Q1 2024 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$27,733,000 |
USD |
-134% |
Q3 2024 |
Q3 2024 |
| Lessee, Operating Lease, Liability, to be Paid |
$149,000 |
USD |
-37% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$90,000 |
USD |
2.3% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$79,000 |
USD |
5.3% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$60,000 |
USD |
-33% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$89,000 |
USD |
3.5% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$13,000 |
USD |
-59% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$4,959,000 |
USD |
135% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$153,207,000 |
USD |
6.7% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$37,000 |
USD |
-26% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$499,000 |
USD |
4.2% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |